Algert Global’s Adamas Pharmaceuticals ADMS Stock Holding History

Algert Global’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,936	Closed	-$78K	–	1175
2021 Q3	$78K	Buy	+15,936	New	+$77.4K	0.01%	983

Algert Global's ADMS Position: Q4 2021 in Review

Algert Global sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 15,936 shares — an estimated $78K sold.

Algert Global first reported a position in ADMS in Q3 2021 and held it in 1 quarter. The position peaked at $78K in Q3 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Algert Global reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Algert Global sold 15,936 Adamas Pharmaceuticals shares in Q4 2021, an estimated $78K.
Algert Global first reported a position in Adamas Pharmaceuticals in Q3 2021 and held it in 1 quarter.
Algert Global's Adamas Pharmaceuticals position peaked at $78K in Q3 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Algert Global's 13F filing for Q4 2021, filed 14 Feb 2022.